{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:11:16Z","timestamp":1783023076743,"version":"3.54.6"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1053\/j.seminoncol.2016.02.021","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T17:40:18Z","timestamp":1456335618000},"page":"370-383","source":"Crossref","is-referenced-by-count":19,"title":["Cutaneous manifestations and management of hematologic neoplasms"],"prefix":"10.1053","volume":"43","author":[{"given":"Olalekan O.","family":"Oluwole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Zic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Douds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ann Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.seminoncol.2016.02.021_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1053\/j.seminoncol.2016.02.021_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma. C","volume":"12","author":"Wilson","year":"2012","journal-title":"lin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib4","series-title":"Clinical hematology","first-page":"1951","article-title":"Cutaneous T cell lymphoma: mycosis fungoides and Sezary syndrome","author":"Zic","year":"2014"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib5","series-title":"Editors. WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"12","key":"10.1053\/j.seminoncol.2016.02.021_bib6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3109\/10428194.2010.504872","article-title":"Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"51","author":"Hui","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol."},{"issue":"18","key":"10.1053\/j.seminoncol.2016.02.021_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1053\/j.seminoncol.2016.02.021_bib11","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1200\/JCO.20.1.205","article-title":"Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed","volume":"20","author":"Keating","year":"2002","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1053\/j.seminoncol.2016.02.021_bib13","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1053\/j.seminoncol.2016.02.021_bib14","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1053\/j.seminoncol.2016.02.021_bib15","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ejh.12405","article-title":"Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer\/T-cell lymphoma","volume":"94","author":"Tsai","year":"2015","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1529-8019.2009.01257.x","article-title":"Controversies in the management of the cutaneous T cell lymphomas","volume":"22","author":"Zic","year":"2009","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1053\/j.seminoncol.2016.02.021_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.5858\/arpa.2014-0298-CC","article-title":"Selected inflammatory imitators of mycosis fungoides: histologic features and utility of ancillary studies","volume":"138","author":"Arps","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United states: increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"issue":"21","key":"10.1053\/j.seminoncol.2016.02.021_bib20","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"issue":"31","key":"10.1053\/j.seminoncol.2016.02.021_bib21","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the Revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer Staging Proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J of Clin Oncol"},{"issue":"18","key":"10.1053\/j.seminoncol.2016.02.021_bib22","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2013.12.029","article-title":"Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement","volume":"70","author":"Hodak","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(95)91337-8","article-title":"Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases","volume":"32","author":"Lambroza","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminoncol.2016.02.021_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/00007611-198610000-00005","article-title":"Erythroderma: review of 82 cases","volume":"79","author":"King","year":"1986","journal-title":"South Med J"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/17474086.2015.984681","article-title":"Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma","volume":"8","author":"Moriarty","year":"2015","journal-title":"Expert Rev Hematol"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","article-title":"TOX expression in different subtypes of cutaneous lymphoma","volume":"306","author":"Morimura","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2009.03.014","article-title":"Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases","volume":"62","author":"Muniesa","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaad.2012.04.015","article-title":"Clinical and histopathologic spectrum of alopecia mucinosa\/follicular mucinosis and its natural history in children","volume":"67","author":"Zvulunov","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib32","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jaad.2009.06.056","article-title":"Folliculotropic mycosis fungoides masquerading as alopecia areata","volume":"63","author":"Iorizzo","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaad.2014.06.033","article-title":"Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patients","volume":"71","author":"de Masson","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.1995.01690150089018","article-title":"Woringer-Kolopp disease (localized pagetoid reticulosis) or unilesional mycosis fungoides? An analysis of eight cases with benign disease","volume":"131","author":"Burns","year":"1995","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1053\/j.seminoncol.2016.02.021_bib35","first-page":"1469","article-title":"Pagetoid reticulosis Woringer-Kolopp type, a particular variant of mycosis fungoides: a case report","volume":"55","author":"Morariu","year":"2014","journal-title":"Rom J Morphol Embryol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib36","first-page":"307","article-title":"Woringer-Kolopp disease mimicking foot dermatitis","volume":"90","author":"Yao","year":"2012","journal-title":"Cutis"},{"issue":"12","key":"10.1053\/j.seminoncol.2016.02.021_bib37","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1468-3083.2012.04513.x","article-title":"Granulomatous slack skin disease: a review, in comparison with mycosis fungoides","volume":"26","author":"Shah","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/0128071-200910010-00004","article-title":"Granulomatous slack skin presenting as acquired ichthyosis and muscle masses","volume":"10","author":"Hsiao","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1684\/ejd.2008.0562","article-title":"Granulomatous slack skin clinically and histologically masquerading as borderline leprosy in its early stages","volume":"19","author":"Pratchyapruit","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib40","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/bjh.13400","article-title":"Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data","volume":"170","author":"Bates","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1053\/j.seminoncol.2016.02.021_bib44","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2169\/internalmedicine.53.2458","article-title":"A subcutaneous panniculitis-like T-cell lymphoma mimicking dermatomyositis","volume":"53","author":"Kaieda","year":"2014","journal-title":"Intern Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib45","doi-asserted-by":"crossref","DOI":"10.5070\/D3202021535","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with unusual eschar-like crusting","volume":"20","author":"Ghosh","year":"2014","journal-title":"Dermatol Online J"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.02.021_bib46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-013-2258-7","article-title":"The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous gammadelta T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases","volume":"32","author":"Yi","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1053\/j.seminoncol.2016.02.021_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1600-0560.2007.00938.x","article-title":"Atypical lymphocytic lobular panniculitis: a clonal subcutaneous T-cell dyscrasia","volume":"35","author":"Magro","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.seminoncol.2016.02.021_bib48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8(+) T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cup.12243","article-title":"The differential diagnosis of CD8-positive (\"type D\") lymphomatoid papulosis","volume":"41","author":"McQuitty","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2016.02.021_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0303-6987.2006.00548.x","article-title":"CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators","volume":"33","author":"Kempf","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1053\/j.seminoncol.2016.02.021_bib51","first-page":"574","article-title":"Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options","volume":"24","author":"Querfeld","year":"2010","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign\u2014histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.021_bib53","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3892\/etm.2014.2006","article-title":"Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: two case reports and a literature review","volume":"8","author":"Zheng","year":"2014","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.rdc.2014.09.011","article-title":"Challenging mimickers of primary systemic vasculitis","volume":"41","author":"Miloslavsky","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1053\/j.seminoncol.2016.02.021_bib55","first-page":"1527","article-title":"The importance of histopathology findings in lymphomatoid papulosis","volume":"55","author":"Gheuca Solovastru","year":"2014","journal-title":"Rom J Morphol Embryol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2340\/00015555-1488","article-title":"Ulcerated nodules on the oral mucosa and fingers: lymphomatoid papulosis, type A","volume":"93","author":"Booken","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/01676830.2014.907813","article-title":"Lymphomatoid papulosis type C of the eyelid in a young girl: a case report and review of literature","volume":"33","author":"Meena","year":"2014","journal-title":"Orbit"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.02.021_bib58","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib60","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/DAD.0b013e3182943394","article-title":"Angioinvasive lymphomatoid papulosis: another case of a newly described variant","volume":"36","author":"Sharaf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib61","first-page":"1","article-title":"Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis","author":"Nikolaou","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1053\/j.seminoncol.2016.02.021_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.det.2015.05.013","article-title":"Practical Management of CD30(+) Lymphoproliferative Disorders","volume":"33","author":"Hughey","year":"2015","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib63","first-page":"331","article-title":"Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry","volume":"10","author":"Booken","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.seminhematol.2013.11.003","article-title":"Pathology of peripheral T-cell lymphomas: where do we stand?","volume":"51","author":"Gaulard","year":"2014","journal-title":"Semin Hematol"},{"issue":"25","key":"10.1053\/j.seminoncol.2016.02.021_bib65","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.seminoncol.2016.02.021_bib66","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib67","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.02.021_bib68","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0000000000000118","article-title":"Expression of the chemokine receptor gene, CCR8, is associated with DUSP22 rearrangements in anaplastic large cell lymphoma","volume":"23","author":"Xing","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1053\/j.seminoncol.2016.02.021_bib72","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib73","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/PPO.0b013e31826aef4a","article-title":"Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma","volume":"18","author":"Foyil","year":"2012","journal-title":"Cancer J"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin Hematol"},{"issue":"17","key":"10.1053\/j.seminoncol.2016.02.021_bib75","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"International Peripheral T-Cell Lymphoma Project. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190400002202","article-title":"Adoptive immunotherapy for EBV-associated malignancies","volume":"46","author":"Gottschalk","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib77","series-title":"Clinical hematology","first-page":"1827","article-title":"Non-hodgkin lymphoma in adults","author":"Greer","year":"2014"},{"issue":"15","key":"10.1053\/j.seminoncol.2016.02.021_bib78","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"issue":"1-2","key":"10.1053\/j.seminoncol.2016.02.021_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","article-title":"Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives","volume":"78","author":"Bazarbachi","year":"2001","journal-title":"Virus Res"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.02.021_bib80","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.seminoncol.2016.02.021_bib81","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.021_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.23863","article-title":"Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management","volume":"90","author":"Wilcox","year":"2015","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib83","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2010.06.059","article-title":"Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment","volume":"65","author":"Gulia","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib84","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification","volume":"69","author":"Suarez","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib85","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/107327481201900308","article-title":"Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management","volume":"19","author":"Sokol","year":"2012","journal-title":"Cancer Control"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib86","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3109\/10428194.2010.504872","article-title":"Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"51","author":"Hui","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib87","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib88","series-title":"Hematopathology: a volume in the series foundations in diagnostic pathology","author":"Hsi","year":"2012"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis\u2014a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1053\/j.seminoncol.2016.02.021_bib91","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.021_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-4632.2006.02675.x","article-title":"Cutaneous manifestations of Hodgkin\u05f3s disease","volume":"45","author":"Rubenstein","year":"2006","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.021_bib93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2005.11.1055","article-title":"Cutaneous Hodgkin\u05f3s disease","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1053\/j.seminoncol.2016.02.021_bib94","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement","volume":"24","author":"Lin","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.seminoncol.2016.02.021_bib95","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1053\/j.seminoncol.2016.02.021_bib96","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5858\/arpa.2013-0101-RS","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review","volume":"138","author":"Shi","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib97","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1309\/AJCP9IS9KFSVWKGH","article-title":"Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm","volume":"137","author":"Cronin","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1053\/j.seminoncol.2016.02.021_bib98","first-page":"1076","article-title":"Mucocutaneous paraneoplastic syndromes associated with hematologic malignancies","volume":"25","author":"Steele","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.1053\/j.seminoncol.2016.02.021_bib99","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0738-081X(00)00192-9","article-title":"Immunopathology of paraneoplastic pemphigus","volume":"19","author":"Hashimoto","year":"2001","journal-title":"Clin Dermatol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T14:04:49Z","timestamp":1748786689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0093775416000464"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.02.021","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}